In this presentation, Kirstie Perrotta, MPH, from UC San Diego and MotherToBaby California, reviews the risks of respiratory viruses such as COVID-19 and flu during pregnancy, including potential impacts such as miscarriage, birth defects, and pregnancy complications. She also covers the latest data and recommendations for COVID-19, flu, Tdap, and RSV vaccines during pregnancy.

The webinar also covers the latest data and clinical guidance on vaccination during pregnancy, including COVID-19, influenza (flu), Tdap, and RSV vaccines. Attendees will learn how current recommendations are designed to protect both pregnant individuals and their infants, and how to communicate these benefits effectively to patients. Practical insights will be provided on integrating vaccine counseling into routine prenatal care, addressing patient concerns, and promoting informed decision-making.

By the end of this session, participants will leave with a better understanding of the benefits of vaccination for both mom and baby. They will also be able to clearly explain the 2024–2025 vaccine recommendations during pregnancy, supporting evidence-based clinical practice and improving maternal and infant health outcomes.

Continuing Education (CE) credits are available for ACNM members and non-members who view this session via the ACNM Online Learning Center.